International ME/CFS Conference 2025 Berlin May 12-13

Discussion in 'ME/CFS research news' started by Jaybee00, Mar 30, 2025.

  1. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    2,492
    Just noticed that all patients in the trial were female. Wonder if there are diseases with very different responses to meds between males and females?
     
  2. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights) Staff Member

    Messages:
    6,858
    Location:
    Aotearoa New Zealand
    I'm not sure when the videos will become available but I'd also highlight Dr Anna Aschenbrenner's talk that came at the end of day 1. Data from paper in preparation.

    Using high-dimensional flow cytometry, they showed changes in NKs. However, they could not find a difference in immune cell subtypes when looking at subgroups based on causative infection (SARS2, EBV, influenza etc). And defined two severity subsets based on transcriptome.

    0 copy.jpg 1 copy.jpg 2 copy.jpg 3 copy.jpg 4 copy.jpg
     
    hotblack, Arfmeister, Trish and 3 others like this.
  3. Arfmeister

    Arfmeister Established Member (Voting Rights)

    Messages:
    58
    Do you remember what the NK-changes exactly are?
    - from the 4th slide, I can see that there are NK cell alterations - higher levels for CD-56
    - with Long Covid and infection onset ME CFS patients (vs healthy controls)
     
    Yann04 likes this.
  4. rapidboson

    rapidboson Senior Member (Voting Rights)

    Messages:
    162
    As somebody has shared a picture of a poster in another thread, I am linking the .zip of all posters.
     
    Jaybee00 and EndME like this.

Share This Page